Comparing PMGC (NASDAQ:ELAB) and Swire Pacific (OTCMKTS:SWRAY)

PMGC (NASDAQ:ELAB) and Swire Pacific (OTCMKTS:SWRAY) are both multi-sector conglomerates companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, analyst recommendations, earnings and risk.

Analyst Recommendations

This is a summary of recent ratings and target prices for PMGC and Swire Pacific, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PMGC	1	0	0	0	1.00
Swire Pacific	0	1	0	0	2.00

Risk and Volatility

PMGC has a beta of 0.28, meaning that its stock price is 72% less volatile than the S&P 500. Comparatively, Swire Pacific has a beta of 0.13, meaning that its stock price is 87% less volatile than the S&P 500.

Insider and Institutional Ownership

22.2% of PMGC shares are held by institutional investors. 0.1% of PMGC shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares PMGC and Swire Pacific’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PMGC	N/A	-80.35%	-61.56%
Swire Pacific	N/A	N/A	N/A

Valuation and Earnings

This table compares PMGC and Swire Pacific”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PMGC	$1.71 million	0.62	-$6.25 million	($16.71)	-0.09
Swire Pacific	$10.50 billion	2.86	$553.95 million	N/A	N/A

Swire Pacific has higher revenue and earnings than PMGC.

Summary

Swire Pacific beats PMGC on 6 of the 9 factors compared between the two stocks.

About PMGC

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

About Swire Pacific

Swire Pacific Limited engages in property, aviation, beverages, marine, and trading and industrial businesses in Hong Kong, Mainland China, rest of Asia, the United States, and internationally. The company's Property division develops, owns, and operates mixed-use properties. This division's property investment portfolio comprises office and retail premises, serviced apartments, and other luxury residential accommodations; and trading portfolio consists of residential properties. It also owns and manages hotels in Hong Kong and hotels in Mainland China, as well as owns interests in the Mandarin Oriental hotel in the United States. The company's Aviation division provides flight catering and ramp, passenger and cargo services, and aircraft maintenance and modification services. As of December 31, 2022, it had a fleet of 222 aircraft. Its Beverages division owns rights to manufacture, market, and distribute beverages to consumers. The company's Trading & Industrial division markets, retails, and distributes footwear, apparel, and accessories through its retail outlets; sells passenger cars, commercial vehicles, motorcycles, and scooters; operates a chain of bakery stores; packages and sells sugar products under the Taikoo Sugar brand; and offers waste management, business consultancy, and financial services. The company was founded in 1816 and is based in Central, Hong Kong. Swire Pacific Limited operates as a subsidiary of John Swire & Sons (H.K.) Limited